Chris Krueger, TD Cowen managing director, joins CNBC's 'The Exchange' to break down the White House's rescinding a memo ...

In a report released today, Charles Rhyee from TD Cowen reiterated a Buy rating on GoodRx Holdings (GDRX – Research Report), with a price ...

Jeff Solomon, TD Cowen president, joins 'Money Movers' to discuss the underlying tone of the AI drama this week, what to ...

CACI International Inc (NYSE: CACI) announced today that it will participate in the TD Cowen 46th Annual Aerospace and ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 45.04% ...

Exxon Mobil Corp (XOM) stock saw a decline, ending the day at $108.04 which represents a decrease of $-2.13 or -1.93% from the prior close of $110.17. The stock opened at $110.41 and touched a low of ...

TD Cowen upgraded Roper Technologies (ROP) to Buy from Hold with a price target of $615, up from $535. Given macroeconomic and policy ...

Atlassian (TEAM) looks to continue its streak of outperforming consensus estimates in fiscal 2025 when it reports its second ...

Guyana production for Hess surged by 52% in the fourth quarter to 195,000 barrels per day of oil, the US operator revealed ...

Salesforce ( CRM 0.70%) has been a leader in cloud software since its inception. In fact, founded as a cloud software company ...

TD Cowen expressed concerns about valuation. “If Celsius can’t demonstrate a path back to growth, it could end up being ...

TD Cowen initiated coverage of KalVista (KALV) with a Buy rating and $30 price target The firm cites sebetralstat’s opportunity as the first oral acute therapy for hereditary angioedema attacks ...